Home › Asset managers › Compare 2023-2024 › Charles Schwab vs John Hancock
Charles Schwab 2023-2024 · John Hancock 2023-2024 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 6,366 | 5,555 | 365 | 446 | 93.8% | 91.0% |
| Board proposals | 5,363 | 4,879 | 281 | 203 | 94.6% | 93.2% |
| E&S shareholder proposals | 221 | 69 | 14 | 138 | 83.1% | 60.0% |
| Other items | 782 | 607 | 70 | 105 | 89.7% | 84.5% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
811 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Charles Schwab | John Hancock |
|---|---|---|---|---|---|---|
| INTEVAC INC. | May 15, 2024 | Proposal to approve an amendment to the Intevac 2020 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 900,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| INTUITIVE SURGICAL INC. | April 25, 2024 | The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan. Compensation |
Board | For | AGAINST 15 funds |
FOR 12 funds |
| INVESCO LTD. | May 23, 2024 | Amendment and restatement of the Invesco Ltd. 2016 Global Equity Incentive Plan to increase the number of authorized shares and make certain other revisions Compensation |
Board | For | FOR 14 funds |
AGAINST 7 funds |
| IROBOT CORP. | October 12, 2023 | To approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to iRobot's named executive officers in connection with the merger; and Say-on-Pay |
Board | For | AGAINST 8 funds |
FOR 4 funds |
| IROBOT CORP. | May 23, 2024 | Approve an amendment to the iRobot Corporation 2018 Stock Option and Incentive Plan, as amended (the "2018 Plan"), to increase the maximum number of shares reserved and issuable under the 2018 Plan. Compensation |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| IVERIC BIO INC. | July 6, 2023 | To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger. Say-on-Pay |
Board | For | AGAINST 6 funds |
FOR 4 funds |
| JETBLUE AIRWAYS CORP. | May 17, 2024 | To approve an amendment to the JetBlue Airways Corporation 2020 Omnibus Equity Incentive Plan to increase the number of shares of common stock authorized for issuance Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| KALVISTA PHARMACEUTICALS INC. | September 26, 2023 | The election of two Class II directors to hold office until the earliest of our 2026 annual meeting of stockholders and such individual's death, resignation or removal and the election and qualification of his or her successor: PATRICK TREANOR Director Elections |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| KANZHUN LIMITED | June 28, 2024 | To re-elect Mr. Yan Li as an independent non-executive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| KARYOPHARM THERAPEUTICS INC. | May 29, 2024 | To approve an amendment to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended, to increase the number of shares of our common stock available for issuance thereunder by 6,000,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to re-elect Mr. Jun Wu as an independent nonexecutive Director. Director Elections |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| KE HOLDINGS INC. | June 14, 2024 | As an ordinary resolution, to re-elect Mr. Yongdong Peng as an executive Director. Director Elections |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| KLX ENERGY SERVICES HOLDINGS INC. | May 9, 2024 | To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers; Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 4 funds |
| KOPIN CORP. | June 6, 2024 | Election of Director: Scott L. Anchin Director Elections |
Board | For | ABSTAIN 1 fund |
FOR 1 fund |
| KRONOS WORLDWIDE INC. | May 15, 2024 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| KURA ONCOLOGY INC. | June 5, 2024 | Approval, on an advisory basis, of the compensation of our named executive officers during the year ended December 31, 2023. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 4 funds |
| LANTRONIX INC. | November 7, 2023 | Election of Directors Hoshi Printer Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| LANTRONIX INC. | November 7, 2023 | Election of Directors Phu Hoang Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| LAZYDAYS HOLDINGS INC. | June 10, 2024 | Approval of an amendment to the 2018 Long-Term Incentive Plan to increase the number of authorized shares of common stock by 1,500,000. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| LEE ENTERPRISES INC. | February 22, 2024 | Approve, by non-binding vote, the Company's compensation of its Named Executive Officers ("Say-On-Pay" vote). Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| LEGACY HOUSING CORP. | December 1, 2023 | Election of Directors Curtis D. Hodgson Director Elections |
Board | For | AGAINST 2 funds |
FOR 4 funds |
| LEMONADE INC. | June 5, 2024 | To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| LENNAR CORP. | April 10, 2024 | Approval, on an advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 14 funds |
FOR 2 funds |
| LI-CYCLE HOLDINGS CORP. | May 23, 2024 | Approve, on an advisory basis, the compensation of Li-Cycle Holdings Corp.'s named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| LIBERTY LATIN AMERICA LTD. | May 21, 2024 | To approve, on an advisory basis, the compensation of our named executive officers as described in the proxy statement under the heading "Executive Officers and Directors Compensation;" and Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 2 funds |
| LIFEWAY FOODS INC. | June 14, 2024 | To approve, by non-binding advisory vote, executive compensation. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| LIGHTWAVE LOGIC INC. | May 22, 2024 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| LINCOLN NATIONAL CORP. | May 23, 2024 | The approval of an amendment to the Lincoln National Corporation 2020 Incentive Compensation Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 8 funds |
| LIQUIDIA CORP. | June 20, 2024 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| LIVEWIRE GROUP INC. | May 16, 2024 | To approve the issuance of additional shares of common stock necessary to effect a full conversion of the Convertible Loan. Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| LOVESAC CO. | June 11, 2024 | To approve Amendment No. 2 of the Second Amended and Restated 2017 Equity Incentive Plan that increases the number of shares reserved for issuance thereunder by 1,100,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| LUFAX HOLDING LTD. | May 30, 2024 | To re-elect Mr. Weidong LI as an Independent non-executive Director. Director Elections |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| LUFAX HOLDING LTD. | May 30, 2024 | To re-elect Mr. Yong Suk CHO as an Executive Director. Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| LUFAX HOLDING LTD. | May 30, 2024 | To re-elect Mr. Yonglin XIE as a Non-executive Director. Director Elections |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| MADRIGAL PHARMACEUTICALS INC. | June 25, 2024 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| MAGENTA THERAPEUTICS INC. | September 8, 2023 | Election of Director: Anne McGeorge Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| MAGENTA THERAPEUTICS INC. | September 8, 2023 | Election of Director: David T. Scadden, M.D. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| MAGENTA THERAPEUTICS INC. | September 8, 2023 | Election of Director: Jeffrey W. Albers Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 1 fund |
| MARATHON DIGITAL HOLDINGS INC. | June 27, 2024 | The approval of an amendment to our Amended and Restated 2018 Equity Incentive Plan (our "2018 Plan") to increase the number of shares of our common stock, par value $0.0001 per share, reserved under our 2018 Plan by 15,000,000, or from 30,000,000 shares to 45,000,000 shares. Compensation |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| MARQETA INC. | June 13, 2024 | To approve, on a non-binding advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 5 funds |
FOR 1 fund |
| MICROCHIP TECHNOLOGY INC. | August 22, 2023 | Proposal to approve an amendment and restatement of our 1994 International Employee Stock Purchase Plan to extend the term of the Plan by ten years to November 30, 2034. Compensation |
Board | For | AGAINST 14 funds |
FOR 8 funds |
| MICROCHIP TECHNOLOGY INC. | August 22, 2023 | Proposal to approve an amendment and restatement of our 2001 Employee Stock Purchase Plan to extend the term of the Plan by ten years to August 31, 2034. Compensation |
Board | For | AGAINST 14 funds |
FOR 8 funds |
| MIDDLESEX WATER CO. | May 21, 2024 | To provide a non-binding advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| MODIVCARE INC. | June 11, 2024 | A non-binding advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| MR. COOPER GROUP INC. | May 23, 2024 | To conduct an advisory vote on named executive officer compensation Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 4 funds |
| MUELLER INDUSTRIES INC. | September 26, 2023 | Approve the amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of common stock by 150,000,000 shares. Capital Structure |
Board | For | AGAINST 8 funds |
FOR 5 funds |
| MULTIPLAN CORP. | April 24, 2024 | Approval of the Amendment to the MultiPlan Corporation 2020 Omnibus Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| MYMD PHARMACEUTICALS INC. | July 31, 2023 | To approve the Agreement and Plan of Merger between the Company and its wholly-owned Delaware subsidiary, MyMD Pharmaceuticals, Inc. ("MyMD Delaware"), pursuant to which the Company will merge with and into MyMD Delaware for the sole purpose of changing the Company's state of domicile, including the approval of the Certificate of Incorporation of MyMD Delaware. Extraordinary Transactions |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| NACCO INDUSTRIES INC. | May 15, 2024 | Proposal to approve, on an advisory basis, NACCO Industries, Inc.'s Named Executive Officer compensation. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 1 fund |
| NECESSITY RETAIL REIT INC (THE) | September 8, 2023 | To approve, by advisory (non-binding) vote, certain compensation arrangements for RTL's named executive officers in connection with the Proposed Transactions discussed under the section titled "The Companies - The Combined Company - Potential Conflicts of Interest of Officers and Directors of GNL and RTL" beginning on page 50. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 4 funds |
| NECESSITY RETAIL REIT INC. | September 8, 2023 | To approve the merger of RTL and GNL, which will be effected through a merger of RTL with and into Osmosis Sub I, LLC ("REIT Merger Sub"), a wholly owned subsidiary of GNL. Extraordinary Transactions |
Board | For | AGAINST 9 funds |
FOR 3 funds |
| NEOGENOMICS INC. | May 23, 2024 | Approval, on an advisory basis, of the Compensation Paid to the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 5 funds |
| NETGEAR INC. | May 30, 2024 | Proposal to approve, on a non-binding advisory basis, a resolution approving the compensation of our Named Executive Officers in the Proxy Statement. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 5 funds |
| NEUMORA THERAPEUTICS INC. | June 13, 2024 | To elect two Class I directors to hold office until the 2027 annual meeting of stockholders or until their successors are elected: Henry O. Gosebruch Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 3 funds |
| NEW YORK COMMUNITY BANCORP INC. | June 5, 2024 | Approval of proposed amendments to the New York Community Bancorp, Inc. 2020 Omnibus Incentive Plan. Compensation |
Board | For | FOR 12 funds |
AGAINST 3 funds |
| NIKOLA CORP. | August 3, 2023 | The approval of an amendment to the Nikola Corporation 2020 Stock Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 30,000,000 shares, which is contingent on the approval of Proposal 2. Compensation |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| NL INDUSTRIES INC. | May 16, 2024 | Nonbinding advisory vote approving named executive officer compensation. Say-on-Pay |
Board | For | FOR 3 funds |
AGAINST 1 fund |
| NORTHERN OIL & GAS INC. | May 23, 2024 | To approve, on an advisory basis, the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 1 fund |
| NOVAVAX INC. | June 13, 2024 | Amendment and restatement of the Novavax, Inc. Amended and Restated 2013 Employee Stock Purchase Plan to increase the number of shares of common stock available for issuance thereunder by 1,000,000 shares, such that the number of shares available for issuance thereunder is the lesser of (a) 2,155,000 shares of common stock increased on January 1 of each year by 5% of the share pool on such January 1 (rounded down to the nearest whole share) and (b) 3,510,264 shares of common stock. Compensation |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| NURIX THERAPEUTICS INC. | May 20, 2024 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 4 funds |
| OIL-DRI CORPORATION OF AMERICA | December 13, 2023 | Approval of the Amended and Restated Oil-Dri Corporation of America 2006 Long Term Incentive Plan which, among other modifications, increases the number of shares authorized for issuance from 1,219,500 shares to 1,719,500 shares and increases the maximum individual grant size in any calendar year to 150,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 4 funds |
| OPENDOOR TECHNOLOGIES INC. | June 14, 2024 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers (Say-on-Pay Vote). Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 6 funds |
| OPTIMIZERX CORP. | June 5, 2024 | Amendment to OptimizeRx Corporation 2021 Equity Incentive Plan to increase the aggregate number of shares of common stock available for awards by 1,950,000 shares to 4,450,000 shares. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| ORGANOGENESIS HOLDINGS INC. | June 20, 2024 | Approval of an amendment to our 2018 Equity Incentive Plan to increase the number of shares of Class A common stock reserved for issuance thereunder by 15,900,000 shares. Compensation |
Board | For | FOR 5 funds |
AGAINST 3 funds |
| ORMAT TECHNOLOGIES INC. | May 8, 2024 | To approve an amendment and restatement of the Company's 2018 Incentive Compensation Plan to increase the total number of shares reserved thereunder. Compensation |
Board | For | AGAINST 9 funds |
FOR 6 funds |
| OUTSET MEDICAL INC. | May 29, 2024 | Advisory vote to approve 2023 named executive officer compensation Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 4 funds |
| PAGSEGURO DIGITAL LTD. | May 24, 2024 | Re-election of Director: Cleveland Prates Teixeira Director Elections |
Board | For | AGAINST 4 funds |
FOR 3 funds |
| PAGSEGURO DIGITAL LTD. | May 24, 2024 | Re-election of Director: Eduardo Alcaro Director Elections |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| PAGSEGURO DIGITAL LTD. | May 24, 2024 | Re-election of Director: Luis Frias Director Elections |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| PAGSEGURO DIGITAL LTD. | May 24, 2024 | Re-election of Director: Maria Judith de Brito Director Elections |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| PAYSAFE LTD. | May 23, 2024 | To approve the re-election of Mr. Eli Nagler as a Class III director in accordance with our Bye-laws. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 3 funds |
| PAYSAFE LTD. | May 23, 2024 | To approve the re-election of Mr. Peter Rutland as a Class III director in accordance with our Bye-laws. Director Elections |
Board | For | FOR 1 fund |
WITHHOLD 3 funds |
| PDS BIOTECHNOLOGY CORP. | June 24, 2024 | To approve an amendment to our Eighth Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorized shares of our common stock from 75,000,000 shares to 150,000,000 shares; Capital Structure |
Board | For | AGAINST 2 funds |
FOR 3 funds |
| PEAKSTONE REALTY TRUST | June 18, 2024 | Approval of an amendment to the Peakstone Realty Trust Second Amended and Restated Employee and Trustee Long-Term Incentive Plan as described in the proxy statement. Compensation |
Board | For | FOR 9 funds |
AGAINST 3 funds |
| PEAKSTONE REALTY TRUST | June 18, 2024 | Approval of, on an advisory (non-binding) basis, the compensation paid to the Company's Named Executive Officers as described in the proxy statement; and Say-on-Pay |
Board | For | FOR 10 funds |
AGAINST 5 funds |
| PENN ENTERTAINMENT INC. | June 4, 2024 | Approval, on an advisory basis, of the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 10 funds |
FOR 1 fund |
| PERIMETER SOLUTIONS SA | May 23, 2024 | To approve the compensation of certain of the non-employee independent directors of the Company for 2023; Compensation |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| PERMIAN RESOURCES CORP. | May 22, 2024 | To approve, by a non-binding advisory vote, the Company's named executive officer compensation. Say-on-Pay |
Board | For | FOR 11 funds |
AGAINST 1 fund |
| PERSPECTIVE THERAPEUTICS INC. | May 31, 2024 | To consider and vote on a proposal to approve an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's outstanding shares of common stock at a ratio of 1:10 (the "Reverse Stock Split"), with such reverse stock split to be effected at such time and date, if at all, as determined by the Company's board of directors in its sole discretion (the "Reverse Stock Split Proposal"). Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| PGT INNOVATIONS INC. | March 18, 2024 | To approve on an advisory (non-binding) basis the compensation that may be paid or become payable to PGTI's named executive officers that is based on or otherwise relates to the merger (referred to as the "merger-related compensation proposal"); Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 5 funds |
| PJT PARTNERS INC. | June 20, 2024 | To approve, on an advisory basis, the compensation of our Named Executive Officers (Proposal 2). Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| PRAXIS PRECISION MEDICINES INC. | November 6, 2023 | Approval of amendments to our Amended and Restated Certificate of Incorporation, to give our Board of Directors discretionary authority to effect a reverse stock split of all of the outstanding shares of our Common Stock, at a ratio ranging from any whole number between 1-for-5 and 1-for-25, as determined by our Board in its discretion (the "Reverse Stock Split Proposal"). Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| PROFRAC HOLDING CORP. | May 30, 2024 | To elect the six (6) nominees identified in the accompanying Proxy Statement to serve as directors for the ensuing year: Matthew D. Wilks Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 3 funds |
| PRUDENTIAL FINANCIAL INC. | May 14, 2024 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 1 fund |
| PULSE BIOSCIENCES INC. | December 19, 2023 | Subject to approval of Proposal 1, to ratify options awarded under the Plan on November 1, 2023 to acquire up to 1,505,000 shares of the Company's common stock. Compensation |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| QIAGEN NV | June 21, 2024 | Proposal to adopt the Remuneration Policy with respect to the Supervisory Board. Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| QIAGEN NV | June 21, 2024 | Proposal to determine the remuneration of the members of the Supervisory Board. Compensation |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| QIAGEN NV | June 21, 2024 | Reappointment of the Supervisory Director: Mr. Lawrence A. Rosen Director Elections |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| QIAGEN NV | June 21, 2024 | Reappointment of the Supervisory Director: Ms. Elizabeth E. Tallett Director Elections |
Board | For | FOR 2 funds |
AGAINST 1 fund |
| QUANTUM-SI INC. | May 15, 2024 | To approve, by a non-binding, advisory vote, of the compensation of our named executive officers, as described in our proxy statement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 4 funds |
| QUOTIENT TECHNOLOGY INC. | August 3, 2023 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement in accordance with Securities and Exchange Commission rules. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 2 funds |
| QUOTIENT TECHNOLOGY INC. | September 1, 2023 | To approve, on an advisory (nonbinding) basis, the compensation that may be paid or become payable to Quotient Technology Inc.'s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. Say-on-Pay |
Board | For | AGAINST 3 funds |
FOR 5 funds |
| RAYMOND JAMES FINANCIAL INC. | February 22, 2024 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 1 fund |
| RED ROBIN GOURMET BURGERS INC. | May 23, 2024 | Approval of the 2024 Performance Incentive Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| REKOR SYSTEMS INC. | April 18, 2024 | Adoption of Charter Amendment to increase authorized common stock. Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| RELMADA THERAPEUTICS INC. | May 24, 2024 | To provide an advisory vote to approve executive compensation. Say-on-Pay |
Board | For | AGAINST 2 funds |
FOR 1 fund |
| RENAISSANCERE HOLDINGS LTD. | May 13, 2024 | To approve, by a non-binding advisory vote, the compensation of the named executive officers of RenaissanceRe Holdings Ltd. as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 14 funds |
AGAINST 2 funds |
| RIVIAN AUTOMOTIVE INC. | June 18, 2024 | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 9 funds |
FOR 1 fund |
| ROSS STORES INC. | May 22, 2024 | Advisory vote to approve the resolution on the compensation of the named executive officers. Say-on-Pay |
Board | For | AGAINST 15 funds |
FOR 1 fund |
| RUMBLEON INC. | July 14, 2023 | To approve an amendment to the RumbleOn, Inc. 2017 Stock Incentive Plan (the "Plan") to increase the number of shares of Class B common stock authorized for issuance under the Plan. Compensation |
Board | For | FOR 2 funds |
AGAINST 2 funds |
← Previous Page 3 of 9 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.